“I appreciate that the SUDOSCAN provides an opportunity to assess risk for neuropathic complications. I find it complementary to retinal imaging to screen for retinopathy and microalbumin screens to assess for renal damage. The report can be shared with the patient right after the test is performed, and the format is easy for patients to understand.
Addressing neuropathy risk is important given the potential for the development of a disabling condition. An abnormal scan directs my focus to optimizing risk factors for the patient and may lead to additional investigations to better characterize the underlying condition.”
– Dr. Erica Hightower, M.D. Staff Endocrinologist – DiabetesTexas